Mach7 Technologies Ltd. · ASX:M7T
Mach7 Technologies — Investor Presentation (April 2019)
22 slides from Mach7 Technologies's investor presentation, Apr 2, 2019
Slide 1: Investor Presentation, April 2019
Investor Presentation, April 2019 For personal use only
Slide 2: Disclaimer 'Forward-Looking' Statements
Disclaimer ‘Forward-Looking' Statements Summary of information: This presentation contains general and background information about Mach7 Technologies Limited (“M7T”) activities current as at the date of the presentation and should not be considered to be comprehensive or to comprise all the informa
Slide 3: Who is Mach7 (ASX:M7T)?
Who is Mach7 (ASX:M7T)? Enterprise Imaging Software provider to hospitals and clinics For personal use only Global imaging market >US$3BN Delivery: On-premise, cloud solutions Growing global customer base: USA, UK, Qatar, South East Asia … Two revenue models: SaaS & capital sales Employi
Slide 4: Mach7 Technologies (M7T:AX)
Mach7 Technologies (M7T:AX) For personal use only FINANCIAL INFORMATION ($A) MAJOR SHAREHOLDERS Share price $0.185 JM Financial Group 13.8% Number of shares (m) 147.8m BV Healthcare 7.9% Market Capitalisation $27.3m Oceania Capital 6.3% Cash (31-Dec-18) $3.2m Ravi Krishnan (founder) 3.8% Debt (31-De
Slide 5: Mach7 Evolution – Company & Product
Mach7 Evolution – Company & Product For personal use only 2007 2010 2012 2016 2017 Mach7 First Pilots First Listed M7T:ASX Expanded Product Founded Deployed Commercial Offerings Wins Specialty Applications: v8 Enterprise Imaging Platform: v11 Data Services Platform: v12 Vendor Neutral Archive Manage
Slide 6: What is Enterprise Imaging
What is Enterprise Imaging Drivers of Enterprise Imaging For personal use only Enterprise imaging Electronic Health Record (EHR) as a precursor • Mach7’s Management Studio underpins our Enterprise Imaging product to Enterprise Imaging • Recent Enterprise Imaging customer wins – HAHK ($15M) Hospital
Slide 7: Mach7 Enterprise Imaging Product Strategy
Mach7 Enterprise Imaging Product Strategy For personal use only Referring Physician Radiologist Vendor Neutral Archive Core Capability is providing Mach7 sells a Picture Archive and (VNA) is the cornerstone Enterprise Imaging (EI) Communications System (PACS) of the EI market solutions for hea
Slide 8: Addressable Global Imaging Market
Addressable Global Imaging Market For personal use only Mach7 Addressable Market* 3,500 • Enterprise Imaging Market (EI) 3,000 $520M* 2018 – with forecast growth 2,500 ~30%* p/a for next two years • EI market is fastest growing market 2,000 • Standalone departmental PACS $2BN 1,500 2018* however mar
Slide 9: Global VNA Market Share, 2017
Global VNA Market Share, 2017 For personal use only Other, 13% IBM Watson Health , 22% Sectra AB* , 3% Mach7 , 3% Agfa Healthcare* , 4% Carestream , 4% Hitachi , 7% GE Healthcare , 17% Hyland Healthcare* , 7% NTT , 8% Fujifilm Medical* *Market Data from Signify Research , 11% 9
Slide 10: Mach7 Management Studio - VNA
“Mach7 Management Studio” - VNA For personal use only Why customers buy a PACS VNA: • Providing additional Many healthcare providers Mach7’s Core storage are moving toward a multi- Product is VNA • Long-term disaster clinical Management Platform “Management Studio” recovery for all content across th
Slide 11: Mach7 Diagnostic Studio - PACS Solution
“Mach7 Diagnostic Studio” - PACS Solution For personal use only An integration platform first → enables speed, performance, flexibility True zero-footprint (ZFP) viewer → NO client-side software One ZFP platform for all users and devices; browser and device agnostic Does NOT have 100% stream
Slide 12: Mach7 Competitive Advantages
Mach7 Competitive Advantages Interoperability across the For personal use only enterprise (connecting all systems, across all ‘ologies’) Customer controls their Attractive own data – easy Price Point user interface and rules engine Very Little Hardware (Lowers cost and Ease of Install accelerates in
Slide 13: Recent Wins – This Quarter (Q3 FY19)
Recent Wins – This Quarter (Q3 FY19) $2.1M / 5 yrs. For personal use only $365k / 5 yrs. $57k $43k $25k Mississippi State Maine Health Loyola Sampson Sentara University (Cardiology University Regional Healthcare Veterinary* viewer Health System* Medical Centre* (Diagnostic (Clinical Portal) integrat
Slide 14: Hospital Authority of Hong Kong
Hospital Authority of Hong Kong For personal use only • Deal value HK$81 Million (~ A$15M) / 5 years • Enterprise Imaging and Viewer for entire Hong Kong territory • The Hospital Authority manages 43 public hospitals and institutions, 48 specialist outpatient clinics and 73 general outpatient clinic
Slide 15: Sentara Healthcare
Sentara Healthcare For personal use only • Enterprise Imaging, Migration & PACS Modernisation Projects • Mach7 VNA and 20 million study migration underway. • Recent PACS modernization contract won $2.1M over 5 years + volume expansion. 100% GM. • Customer Objectives • Reduce complexities and costs r
Slide 16: Mach7 Customer Examples
Mach7 Customer Examples For personal use only • Academic medical • Partners Healthcare • Academic medical center System center serving the State of Vermont • Enterprise Imaging • Academic medical Platform centers • Client since 2017 • Client since 2014 • Client since 2010 • Academic medical • 1 of 1
Slide 17: Mach7 Customer Examples
Mach7 Customer Examples For personal use only • Qatar’s leading • Statewide • 443-bed acute care hospital system healthcare provider hospital system • 12 + hospitals • Enterprise Imaging • 30+ hospitals and Platform • Client since 2009 clinics • Client since 2018 • Client since 2016 • US & UK provid
Slide 18: Revenue Models
Revenue Models For personal use only Capital Sales Subscription Sales Revenue Component Priced Revenue Recognised Priced Revenue Recognised Upfront when license is Software license fees By Procedure Volume By Procedure Volume Monthly* provided Annual support % of License Monthly* By Procedure Volume
Slide 19: Revenues
Revenues For personal use only Annual Recurring Revenue (ARR) A$ 8,000,000 • Total Contracted ARR 50% growth 7,000,000 (today v ’18) 6,000,000 • Yearly ARR 30% growth (FY19 est. 5,000,000 vs ‘18) 4,000,000 • On track to exceed FY2018 total 3,000,000 revenue of $8.6M with existing 2,000,000 contracts
Slide 20: Growth Strategy
Growth Strategy Focus on core products: enterprise imaging market For personal use only space Focus on allocating resources towards commercial side of the business: sales, marketing, product management Focus on major markets where we already have an install base and good brand recognition: USA, Asia
Slide 21: What's next? Next six months…
What’s next? Next six months… For personal use only Continued progress to cashflow break-even for 12 months ending March 2020 Revenue growth FY 2019 vs 2018 Contract wins Re-investing some cost savings into commercial roles 21
Slide 22: Mach7 Board and Leadership Team
Mach7 Board and Leadership Team only MANAGEMENT Mike Jenni Pilcher Damien Lim Eliot Siegel, MD Lampron CFO, Company For personal useBOARD NON-EXECUTIVE NON-EXECUTIVE CEO Secretary CHAIRMAN DIRECTOR Executive experience in ASX- Thought leader in the world of 20+ years experience in listed healt
Mach7 Technologies — Investor Presentation (April 2019) on 6ix